Loading company
Loading
Latest quarter · Q2 FY2026
Millions- Total revenues
- 1
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
CHINA PHARMA HOLDINGS, INC. (CPHI) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $4.1 million | $4.5 million | -8.5% | 10-K 2026-04-01 · proof |
| Gross profit | -$131,950 | -$2 million | 10-K 2026-04-01 · proof | |
| Operating income | -$3.2 million | -$4.6 million | 10-K 2026-04-01 · proof | |
| Net income | -$3.2 million | -$4.7 million | 10-K 2026-04-01 · proof | |
| Cash from operating activities | $148,261 | -$406,063 | 10-K 2026-04-01 · proof | |
| Free cash flow | $88,937 | -$444,474 | 10-K 2026-04-01 · proof | |
| Total assets | $31 million | $14.9 million | +108.2% | 10-K 2026-04-01 · proof |
| Total liabilities | $8.3 million | $7.1 million | +15.7% | 10-K 2026-04-01 · proof |
| Cash and cash equivalents | $345,112 | $626,879 | -44.9% | 10-K 2026-04-01 · proof |
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s revenue in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported revenue of $4.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $4.5 million the year before (-8.5%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s gross profit in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported gross profit of -$131,950 for fiscal 2025 (the year ended Dec 31, 2025), against -$2 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s operating income in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported operating income of -$3.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s net income in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported net income of -$3.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4.7 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s cash from operating activities in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported cash from operating activities of $148,261 for fiscal 2025 (the year ended Dec 31, 2025), against -$406,063 the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was CHINA PHARMA HOLDINGS, INC. (CPHI)'s free cash flow in fiscal 2025?
- CHINA PHARMA HOLDINGS, INC. (CPHI) reported free cash flow of $88,937 for fiscal 2025 (the year ended Dec 31, 2025), against -$444,474 the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are CHINA PHARMA HOLDINGS, INC. (CPHI)'s total assets?
- As of Dec 31, 2025, CHINA PHARMA HOLDINGS, INC. (CPHI) reported total assets of $31 million, against $14.9 million a year earlier (+108.2%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are CHINA PHARMA HOLDINGS, INC. (CPHI)'s total liabilities?
- As of Dec 31, 2025, CHINA PHARMA HOLDINGS, INC. (CPHI) reported total liabilities of $8.3 million, against $7.1 million a year earlier (+15.7%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are CHINA PHARMA HOLDINGS, INC. (CPHI)'s cash and cash equivalents?
- As of Dec 31, 2025, CHINA PHARMA HOLDINGS, INC. (CPHI) reported cash and cash equivalents of $345,112, against $626,879 a year earlier (-44.9%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CPHI&period_type=annual&limit=5"Information only, not investment advice.